FEZF1 and ovarian carcinoma: Further studies have identified that FEZF1-AS1 activated the Janus Kinase (JAK)-signal transducer and activator of transcription 3 (STAT3) signaling pathway by regulating the phosphorylation of STAT3, promoting the proliferation of ovarian cancer cells and inhibiting apoptosis [23].